We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.21B
AUM Growth
+$330M
Cap. Flow
+$275M
Cap. Flow %
22.73%
Top 10 Hldgs %
36.41%
Holding
4,516
New
1,790
Increased
1,264
Reduced
722
Closed
680

Sector Composition

Rank Sector Weight
1 Financials 6.31%
2 Technology 5.59%
3 Industrials 5.06%
4 Consumer Discretionary 3.68%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJI
451
DELISTED
South Jersey Industries, Inc.
SJI
$322K 0.03%
+9,309
New +$323K
SCHA icon
452
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$321K 0.03%
19,080
-97,732
-84% -$1.57M
BCPC
453
Balchem Corp
BCPC
$5.38B
$321K 0.03%
3,942
+3,863
+4,890% +$297K
ABCO
454
DELISTED
Advisory Board Co
ABCO
$321K 0.03%
5,976
+5,876
+5,876% +$317K
DUK icon
455
Duke Energy
DUK
$97.8B
$320K 0.03%
3,809
+2,666
+233% +$228K
ILCG icon
456
iShares Morningstar Growth ETF
ILCG
$3.11B
$320K 0.03%
10,930
-3,000
-22% -$86.4K
SMTC icon
457
Semtech
SMTC
$11B
$320K 0.03%
+8,526
New +$318K
TCF
458
DELISTED
TCF Financial Corporation Common Stock
TCF
$320K 0.03%
+6,122
New +$292K
CPB icon
459
Campbell Soup
CPB
$6.55B
$318K 0.03%
6,795
+6,219
+1,080% +$315K
AVNT icon
460
Avient
AVNT
$3.33B
$317K 0.03%
+7,923
New +$296K
BIS icon
461
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.32M
$317K 0.03%
1,922
-415
-18% -$74.8K
AAN.A
462
DELISTED
The Aaron's Company Inc Class A
AAN.A
$317K 0.03%
+7,270
New +$317K
PAYX icon
463
Paychex
PAYX
$41.6B
$316K 0.03%
+5,277
New +$301K
PRMW
464
DELISTED
Primo Water Corporation
PRMW
$316K 0.03%
16,931
+16,382
+2,984% +$248K
FCFS icon
465
FirstCash
FCFS
$8.85B
$315K 0.03%
+4,991
New +$295K
HTH icon
466
Hilltop Holdings
HTH
$2.26B
$315K 0.03%
+12,101
New +$304K
SAIC icon
467
Saic
SAIC
$4.95B
$314K 0.03%
+4,687
New +$325K
ALGT icon
468
Allegiant Air
ALGT
$2.64B
$313K 0.03%
2,376
+2,276
+2,276% +$293K
WRLD icon
469
World Acceptance Corp
WRLD
$834M
$313K 0.03%
3,771
+2,208
+141% +$170K
MTOR
470
DELISTED
MERITOR, Inc.
MTOR
$313K 0.03%
+12,043
New +$239K
CMPR icon
471
Cimpress
CMPR
$2.39B
$312K 0.03%
+3,191
New +$296K
WSM icon
472
Williams-Sonoma
WSM
$26.9B
$311K 0.03%
+12,464
New +$290K
KBR icon
473
KBR
KBR
$4.64B
$310K 0.03%
+17,351
New +$281K
WMGI
474
DELISTED
Wright Medical Group Inc
WMGI
$310K 0.03%
+11,971
New +$330K
ELME
475
Elme Communities
ELME
$143M
$308K 0.03%
+9,406
New +$306K

Similar funds

Tower Research Capital (TRC)'s Q3 2017 Portfolio in Review

As of Q3 2017, Tower Research Capital (TRC) held 4,516 positions worth $1.21B, up 37% from $881M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $275M of net new capital in Q3 2017, opening 1,790 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 2.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $60M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2017 buy was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $60M.
  • Tower Research Capital (TRC) fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2017, selling an estimated $17.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $1.21B portfolio in Q3 2017.
  • Tower Research Capital (TRC) opened 1,790 new positions and closed 680 in Q3 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.21B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.